Intended for healthcare professionals

News

US Supreme Court questions legitimacy of case seeking to ban mifepristone

BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q763 (Published 27 March 2024) Cite this as: BMJ 2024;384:q763
  1. Janice Hopkins Tanne
  1. New York

US Supreme Court justices appeared sceptical when hearing oral arguments in a case seeking to ban mifepristone, questioning the legitimacy of the group that brought the case and largely ignoring the question of whether mifepristone should be banned.1

Last year the Alliance for Hippocratic Medicine, which says it values the sanctity of life from fertilisation to natural death, sued the Food and Drug Administration (FDA) in a lower court, claiming that mifepristone, one of two drugs used in medication abortions, was dangerous to women and had been wrongly approved. The judge ordered FDA to take mifepristone off the market but the ruling was suspended and …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription